Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-020786
Filing Date
2025-07-31
Accepted
2025-07-31 18:57:22
Documents
1
Period of Report
2025-07-29

Document Format Files

Seq Description Document Type Size
1 form4-07312025_100718.html 4  
1 form4-07312025_100718.xml 4 4021
  Complete submission text file 0001415889-25-020786.txt   5537
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Issuer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IMMUNOME, INC. 665 STOCKTON DRIVE, SUITE 300 PA 19341
Business Address
Lechleider Robert (Reporting) CIK: 0001997584 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39580 | Film No.: 251173243